SAN DIEGO, CALIFORNIA–(Marketwired – Dec. 3, 2016) – Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX:TR), a clinical-stage immuno-oncology company developing innovative therapies [...]
TORONTO, ONTARIO–(Marketwired – Dec. 2, 2016) – Rubicon Minerals Corporation (TSX:RMX) (“Rubicon” or the “Company“) announces that the resolution (the [...]